肾癌合并尿毒症透析患者的后腹腔镜手术治疗及围手术期综合处理


  【摘要】 目的:分析7例肾癌合并尿毒症透析患者行后腹腔镜手术治疗及围手术期处理的经验。方法:对本科2013年1月-2016年2月期间7例肾癌合并尿毒症患者实施后腹腔镜下根治性肾切除术,分析患者行后腹腔镜手术治疗及围手术期的综合处理情况。结果:7例手术时间67~115 min,平均(87±12.5)min;术中出血量55~120 mL,平均(82.0±13.5)mL,术中生命体征及循环稳定。1例在术后
  5 d出现急性心功能衰竭,经强心、利尿等抢救后心功能恢复,术后病理均为肾透明细胞癌。结论:对于肾癌合并尿毒症患者实施后腹腔镜根治性肾切除手术治疗,需严格术前准备及评估,术中有效麻醉监护及技术操作,术后控制液体摄入量,加强围手术期综合处理,保障尿毒症患者医疗安全和治疗效果。
  【关键词】 肾癌; 尿毒症; 腹腔镜; 综合治疗; 根治性肾切除
  Laparoscopic Surgery and Combined Perioperative Management of Kidney Cancer Patients Accompanied with Uremia in Hemodialysis/ZHU Zunwei,ZHOU Jie,XIONG Huanteng,et al.//Medical Innovation of China,2018,15(07):091-095
  【Abstract】 Objective:To analyze clinical experience in laparoscopic surgery and perioperative management of 7 kidney cancer patients accompanied with uremia in hemodialysis.Method:7 kidney cancer patients accompanied with uremia in our department were selected from January 2013 to February 2016,they were given radical nephrectomy.The comprehensive treatment of patients undergoing retroperitoneal laparoscopic surgery and perioperative period were analyzed.Result:The operation time was about 67-115 min,average (87.0±12.5) min;
  operative blood loss about 55-120 mL,average (82.0±13.5)mL.The vital signs during operation were stable.1 case had acute heart failure at the fifth day after surgery,but recuperated after emergency treatment.Their postoperative pathologic results were all renal clear cell carcinoma.Conclusion:To have laparoscopic radical nephrectomy for kidney cancer patients accompanied with uremia,we must have good preoperative preparation,monitoring andcontrol the effect of anaesthesia during operation, restriction of fluid intake after the operation,and reinforce combined perioperative management for medication safety and treatment effect.
  【Key words】 Kidney cancer; Uremia; Laparoscopic; Combined treatment; Radical nephrectomy
  First-author’s address:Jiangxi Province People’s Hospital,Nanchang 330006,China
  doi:10.3969/j.issn.1674-4985.2018.07.026
  尿毒癥是慢性肾功能衰竭发展至最严重的阶段,系代谢终末产物和内源性毒性物质在体内潴留,水电解质和酸碱平衡发生紊乱以及某些内分泌功能失调而引发的一系列自体中毒症状。患者机体免疫能力下降,容易并发肿瘤形成。肾癌即肾细胞癌,起源于肾小管上皮细胞,又称肾腺癌。对于尿毒症长期透析维持的患者合并肾癌,具备手术指征,从改善患者生存的角度出发,需行手术治疗。但尿毒症系手术的相对禁忌受长时间血透治疗影响,各系统已出现功能障碍和物质代谢紊乱,极易出现围手术期并发症,特别是实施后腹腔镜下手术。因此,此类患者围手术期的综合处理非常重要。本科2013年
  1月-2016年2月期间,对7例肾癌合并尿毒症的患者实施腹腔镜下根治性肾切除术,取得一定经验,现汇报如下。
  1 资料与方法
  1.1 一般资料 肾癌合并尿毒症透析患者7例,男3例,女4例;31~59岁;肿瘤均为单发,左侧5例,右侧2例;肿瘤位于肾上极1例,肾中部4例,肾下极2例;大小2.5~4.5 cm,均无肉眼血尿,均未发现淋巴结、肾上腺、远处脏器转移及腔静脉、肾静脉瘤栓形成。患者日常均在肾内科每周规律行血液透析2~3次,维持血透时间19~62个月,日尿量0~1 500 mL,肾功能衰竭的原因均为慢性肾小球肾炎所致。纳入标准:均先后经泌尿系彩超、CT平扫及增强扫描检查,符合影像学诊断肾癌。排除标准:合并严重心肺功能障碍等疾病;合并广泛肿瘤转移,存在影响手术操作的出凝血性障碍性疾病,以及有后腹腔镜手术禁忌证,不能耐受全身麻醉者。经医院伦理委员会审批并报医务部门备案后实施。

推荐访问:肾癌 尿毒症 透析 合并 手术治疗